Gene: ZRANB3
Official Full Name: zinc finger RANBP2-type containing 3provided by HGNC
Gene Summary: Enables ATP-dependent DNA/DNA annealing activity; DNA endonuclease activity; and K63-linked polyubiquitin modification-dependent protein binding activity. Involved in several processes, including DNA metabolic process; DNA rewinding; and negative regulation of DNA recombination. Located in nuclear replication fork and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25208 | ZRANB3 Knockout cell line (HeLa) | Human | ZRANB3 | 1:3~1:6 | Negative | Online Inquiry |
KO25209 | ZRANB3 Knockout cell line (HCT 116) | Human | ZRANB3 | 1:2~1:4 | Negative | Online Inquiry |
KO25210 | ZRANB3 Knockout cell line (HEK293) | Human | ZRANB3 | 1:3~1:6 | Negative | Online Inquiry |
KO25211 | ZRANB3 Knockout cell line (A549) | Human | ZRANB3 | 1:3~1:4 | Negative | Online Inquiry |
ZRANB3 Gene Knockout Cell Lines are genetically engineered cell lines designed to lack the ZRANB3 gene, providing a powerful tool for investigating the functional roles of this gene in various biological processes. The ZRANB3 gene encodes a protein that is implicated in numerous cellular pathways, including DNA repair, RNA processing, and cellular stress responses. These knockout cell lines facilitate the study of the gene's contributions to these processes by allowing researchers to observe the resultant phenotypic changes as a direct consequence of ZRANB3 deletion.
The functionality of ZRANB3 Gene Knockout Cell Lines lies in their ability to be employed in a variety of experimental setups, including biochemical assays, gene expression analysis, and drug response evaluations. By analyzing how cells lacking ZRANB3 behave in the presence of various stimuli or treatments, researchers can elucidate the gene's roles in tumorigenesis, cellular differentiation, and other critical areas of study. As such, these cell lines are invaluable in advancing our understanding of diseases where ZRANB3 is implicated, particularly cancer and genetic disorders.
Compared to conventional cell lines that express ZRANB3, our knockout lines offer unique advantages such as enhanced specificity in gene function studies and the ability to model human disease states with greater accuracy. This specificity enables researchers to generate more reliable and interpretable results, thus accelerating the pace of discoveries in molecular biology and genetics.
For researchers and clinicians who are focused on the molecular mechanisms underlying disease processes, ZRANB3 Gene Knockout Cell Lines provide a valuable experimental platform that can lead to new insights and therapeutic targets. They are instrumental in high-throughput screening applications and can also be incorporated into CRISPR-based research projects.
Our company prides itself on delivering high-quality biological products backed by robust scientific expertise and commitment to advancing research and clinical applications. With these knockout cell lines, we aim to empower researchers with reliable tools to push the frontiers of knowledge in genetics and cell biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.